Immatics (IMTX) Minority Interest (2019 - 2020)
Immatics' (IMTX) quarterly Minority Interest came in at -$664105.4 in Q4 2020, up 34.5% year-on-year from -$493756.9 in Q1 2020, and down 2.07% quarter-over-quarter from -$650619.0 in Q3 2020.
Immatics (IMTX) Minority Interest (2019 - 2020) Analysis & Trends
Immatics has disclosed Minority Interest across 2 years of filings, most recently posting -$664105.4 for Q4 2020.
- Minority Interest for Q4 2020 came in at -$664105.4, up 34.5% year-over-year; the trailing twelve-month figure through Dec 2020 was -$664105.4 (up 34.5% YoY), and the FY2020 annual result was -$664105.4, up 34.5% from the prior year.
- Minority Interest came in at -$664105.4 for Q4 2020 at Immatics, down from -$650619.0 in the prior quarter.
- In the past five years, Minority Interest ranged from a high of -$302479.3 in Q1 2020 to a low of -$1.0 million in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | -664,105.45 |
| Sep 30, 2020 | -650,619.02 |
| Jun 30, 2020 | -613,513.29 |
| Mar 31, 2020 | -302,479.29 |
| Dec 31, 2019 | -1.01 Mn |
| Sep 30, 2019 | -768,896.45 |
| Jun 30, 2019 | -482,041.17 |